Onemednet Corp (ONMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,129 | -33,780 | -30,451 | 5,136 | N/A |
| Depreciation Amortization | 57 | 28 | 25 | N/A | N/A |
| Accounts receivable | -61 | -133 | 73 | N/A | N/A |
| Other Working Capital | 1,496 | 482 | -29 | -6,118 | N/A |
| Other Operating Activity | 1,654 | 28,612 | 25,679 | 604 | 0 |
| Operating Cash Flow | $-6,983 | $-4,791 | $-4,703 | $-379 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -51 | -44 | -58 | N/A | N/A |
| Purchase Of Investment | -2,900 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 969 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -117,300 | 0 |
| Investing Cash Flow | $-1,982 | $-44 | $-58 | $-117,300 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,850 | 5,675 | 5,140 | N/A | N/A |
| Debt Issued | 2,000 | 454 | 0 | 79 | N/A |
| Debt Repayment | N/A | N/A | N/A | -79 | N/A |
| Common Stock Issued | 6,070 | N/A | 8 | 118,578 | N/A |
| Other Financing Activity | -830 | -1,518 | -815 | -446 | 0 |
| Financing Cash Flow | $9,090 | $4,611 | $4,333 | $118,132 | $N/A |
| Beginning Cash Position | 47 | 271 | 699 | N/A | N/A |
| End Cash Position | 172 | 47 | 271 | 453 | N/A |
| Net Cash Flow | $125 | $-224 | $-428 | $453 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,983 | -4,791 | -4,703 | -379 | N/A |
| Capital Expenditure | -51 | -44 | -58 | N/A | N/A |
| Free Cash Flow | -7,034 | -4,835 | -4,761 | -379 | 0 |